Oxivir 1 is effective against C. auris and a broad spectrum of pathogens in just 1 minute.
Oxivir 1 is the first non-bleach disinfectant specifically approved as effective against C. auris by the EPA. The EPA recognizes that C. auris is a serious public health threat, particularly in healthcare settings, and until now, there have been no EPA-approved products specifically registered to control C. auris. Oxivir 1 products have now been tested and passed EPA’s review to secure registration of this emerging, and difficult-to-kill pathogen. This applies to both RTU and Wipes, EPA registration Nos. 70627-74 and 70627-77, respectively.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.